Adhera Therapeutics Inc
ATRX · PINKDay Range
52 Week Range
Market Cap
722USD
About
General Information
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00687E1091
CUSIP
56804Q300
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
-5.09
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.17
Wall Street Target Price
-
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Profitability
Revenue TTM
132,000
Gross Profit TTM
-157,000
EBITDA
-1,955,000
Profit Margin
0.00%
Return On Assets TTM
-532.88%
Return On Equity TTM
0.00%
Revenue Per Share TTM
0.012
Qtly Revenue Growth YOY
-62.20%
Diluted Eps TTM
-1.17
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
8.2348
Price Book MRQ
0
Enterprise Value Revenue
54
Enterprise Value EBITDA
11
Peers analysis
- CMXHFCSL Limited
169.54
3.19% - CSLLYCSL Ltd
86.83
0.51% - ARGNFargenx SE
655.00
0.00% - UCBJFUCB SA
194.85
0.00% - ALNYAlnylam Pharmaceuticals Inc
240.51
-7.01%
- REGNRegeneron Pharmaceuticals Inc
694.00
-3.22% - BNTXBioNTech SE
112.43
-1.09% - ARGXargenx NV ADR
665.60
-0.72% - VRTXVertex Pharmaceuticals Inc
412.28
-0.27% - UCBJYUCB SA ADR
97.63
-0.27%
